Helus Pharma Announces Results of Annual and Special Meeting of Shareholders and Effective Date for Legal Name Change
Helus Pharma shareholders approved all proposals at the September 22, 2026 annual and special meeting, including the legal name change from Cybin Inc. to Helus Pharma Inc. with 99.3% support. The name change takes effect October 1, 2026 and follows the January 2026 adoption of the Helus Pharma business name, reflecting the company's anticipated shift toward commercial readiness.
Key figures
- Shares represented
- 46452598
- Shareholders present
- 107
- Name change vote for pct
- 99.315%
- Pct outstanding represented
- 63.58%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.